Literature DB >> 36249611

COVID-19 and Sepsis in an Atypical Case of Mixed Connective Tissue Disorder Presenting With a Myasthenic Crisis.

Lav Kumar Shah1, Biswas Pant2, Nashruva Mony3, Sumitanand Mishra4, Januka Gaire5, Sandesh Sharma6.   

Abstract

Myasthenia gravis (MG) is an autoimmune illness that causes neuromuscular junctions to be damaged by anti-acetylcholine receptor antibodies. It is a very rare condition that is more common among women. Fatigable fluctuating diplopia or ptosis is the characteristic early appearance of this condition. Dysphagia or dysphonia may be present in rare cases. This illness can affect any group of skeletal muscles, including those in the neck and upper limbs. It can also affect the muscles that help you breathe, which can lead to breathing failure. We present a case of a 20-year-old female diagnosed with mixed connective tissue disease presenting with acute respiratory failure as the initial presentation of MG. Clinicians have to have a high index of suspicion for myasthenia when patients arrive with fatigable muscle weakness. This will cut down on the amount of money spent on investigations and the risk of morbidity.
Copyright © 2022, Shah et al.

Entities:  

Keywords:  acute polymyositis; covid-19; mixed connective tissue disease; myasthenic crisis; neuromuscular junction; systemic lupus erythema; systemic scleroderma

Year:  2022        PMID: 36249611      PMCID: PMC9556605          DOI: 10.7759/cureus.29092

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

1.  Myasthenia gravis: Five new things.

Authors:  Jeffrey M Statland; Emma Ciafaloni
Journal:  Neurol Clin Pract       Date:  2013-04

2.  Myasthenic crisis.

Authors:  Linda C Wendell; Joshua M Levine
Journal:  Neurohospitalist       Date:  2011-01

3.  Factors associated with acute exacerbations of myasthenia gravis.

Authors:  Rohit Reddy Gummi; Natalie Anna Kukulka; Chelsea B Deroche; Raghav Govindarajan
Journal:  Muscle Nerve       Date:  2019-09-10       Impact factor: 3.217

4.  Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study.

Authors:  Chad Heatwole; Nicholas Johnson; Robert Holloway; Katia Noyes
Journal:  J Clin Neuromuscul Dis       Date:  2011-12

5.  The management and outcome of patients with myasthenia gravis treated acutely in a neurological intensive care unit.

Authors: 
Journal:  Eur J Neurol       Date:  1998-03       Impact factor: 6.089

Review 6.  Neuromuscular Junction Formation, Aging, and Disorders.

Authors:  Lei Li; Wen-Cheng Xiong; Lin Mei
Journal:  Annu Rev Physiol       Date:  2017-12-01       Impact factor: 19.318

Review 7.  Therapy of myasthenic crisis.

Authors:  J Berrouschot; I Baumann; P Kalischewski; M Sterker; D Schneider
Journal:  Crit Care Med       Date:  1997-07       Impact factor: 7.598

8.  On the concept of myasthenic crisis.

Authors:  Richard S Bedlack; Donald B Sanders
Journal:  J Clin Neuromuscul Dis       Date:  2002-09

9.  Myasthenia gravis presenting as isolated respiratory failure.

Authors:  K M Dushay; J D Zibrak; W A Jensen
Journal:  Chest       Date:  1990-01       Impact factor: 9.410

10.  Myasthenic Crisis In Pregnancy.

Authors:  David M French; E Page Bridges; Matthew C Hoskins; Charles M Andrews; Cecil H Nelson
Journal:  Clin Pract Cases Emerg Med       Date:  2017-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.